Systemic Treatment of Moderate to Severe Psoriasis in Pediatric Patients in Galicia, Spain: A Descriptive Study

A Batalla1, R Fernández-Torres2, L Rodríguez-Pazos3

  • 1Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España.

Insights

Systemic treatments for pediatric psoriasis, including phototherapy and methotrexate, are effective and well-tolerated. Most young patients showed good response rates, with minimal adverse effects and no treatment discontinuations.

Area of Science:

  • Dermatology
  • Pediatric Medicine
  • Pharmacology

Background:

  • Limited research exists on systemic therapies for pediatric psoriasis.
  • Psoriasis in children requires effective and safe treatment options.

Purpose of the Study:

  • To document systemic treatments for moderate to severe psoriasis in pediatric patients.
  • To evaluate the effectiveness and safety of these treatments in children.

Main Methods:

  • A multicenter, cross-sectional study of pediatric patients (<18 years) with moderate to severe psoriasis.
  • Data collection included demographics, treatments (systemic drugs, phototherapy), tolerance, adverse effects, and response.

Main Results:

  • Phototherapy and methotrexate were the most common treatments.
  • Good response rates were observed: 66% at 12 weeks (including phototherapy) and 36% at 24 weeks (systemic treatment only).
  • Treatments were well-tolerated, with a 97% tolerance rate and only 11% reporting adverse effects.

Conclusions:

  • Phototherapy and methotrexate are key treatments for pediatric psoriasis.
  • These therapies demonstrate a favorable safety profile and good efficacy in young patients.
  • Systemic treatments offer a viable option for managing moderate to severe psoriasis in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296
Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
699
Eulerian and Lagrangian Flow Descriptions01:22

Eulerian and Lagrangian Flow Descriptions

Fluid flow analysis is critical in many scientific and engineering disciplines, and two principal approaches are used to describe this flow: the Eulerian and Lagrangian methods. These methods offer different perspectives on monitoring and analyzing the motion of fluids, each with distinct advantages depending on the scenario.
The Eulerian method focuses on fixed points in space where fluid properties, such as velocity, pressure, and temperature, are observed as the fluid moves between these...
2.0K